Thailand Peptides
Get in Contact
Catalog
PeptidesCategories
Research
CompareInformation
Calculator
Get in Contact
Comparison · Longevity & Cellular

Epithalon vs GHK-Cu

Epithalon and GHK-Cu are two of the most-studied longevity peptides but target separate cellular-aging processes. Epithalon modulates telomerase and pineal function. GHK-Cu modulates a broad gene-expression programme associated with tissue regeneration.

Bangkok research desk ·

Side-by-side

Epithalon GHK-Cu
MechanismTetrapeptide; telomerase and pineal modulation.Copper tripeptide; gene-expression modulation; tissue regeneration.
Half-lifeShort.Short.
Dose5-10 mg daily SC.1-2 mg daily SC or topical.
Cycle10-20 day pulse, 2×/year.Ongoing.
Research contextSoviet-era research; Western replication limited1.Extensive in vitro gene-expression data; skin regeneration trials2.
Cost tierLow-to-mid.Low.

Epithalon and GHK-Cu often appear in the same longevity-research surveys but work on different problems. Epithalon is a short tetrapeptide from the Khavinson programme, studied for telomerase regulation and pineal-gland effects1. The evidence base is dominated by Soviet-era research, which limits independent Western replication; research should treat specific telomerase-activation claims as hypothesis-stage rather than established.

GHK-Cu has a deeper and more modern evidence base2. The tripeptide is naturally occurring, declines with age, and modulates expression of approximately 4000 human genes in vitro. Research applications lean toward skin regeneration, wound healing, and tissue remodelling. Topical and subcutaneous routes are both used. GHK-Cu research is still predominantly in vitro and preclinical, but the volume and quality of evidence is substantially greater than for Epithalon.

Research-protocol selection depends on the endpoint. Telomere biology or senescence-marker research points to Epithalon. Skin, hair, or tissue-remodelling research points to GHK-Cu. The two can coexist in a longevity-focused protocol because mechanisms do not overlap, but neither has strong trial-derived evidence that their combination produces additional effect. See Epithalon telomerase research for the Epithalon depth treatment.

Frequently asked

Which has stronger research?
GHK-Cu has the deeper and more contemporary evidence base, particularly for skin regeneration and gene-expression modulation2. Epithalon's evidence is older and has limited Western replication.
Is copper toxicity a concern with GHK-Cu?
Physiological doses in research protocols do not approach copper-toxicity thresholds. Wilson's disease is a specific contraindication because of compromised copper handling.
Do they overlap in mechanism?
No. Epithalon acts on telomerase and pineal function. GHK-Cu acts on gene expression and tissue remodelling. Combined use is mechanistically coherent but unsupported by trial data.
Research desk
Ordering both Epithalon and GHK-Cu for a research protocol? The Bangkok desk handles pricing, COA, and timing on WhatsApp.
Open a line with the research desk ≥98% HPLC purity · supplier COA on file · Bangkok-based

Go deeper

Related comparisons

References

  1. Khavinson VK, et al. Peptide Epitalon activates chromatin at the old age. Neuro Endocrinol Lett. 2003. PMID: 14647006
  2. Pickart L, et al. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015. PMID: 26236730

All references verified against PubMed via NCBI E-utilities.